Pharmaceutical Lawyer Joins Norton Rose Fulbright in New York

Robin Adelstein, former North American General Counsel of Sandoz, has joined Norton Rose Fulbright's New York office as a partner. (Photo: Business Wire)

NEW YORK--()--Global legal practice Norton Rose Fulbright today announced that Robin Adelstein, former North American General Counsel of Sandoz, the generics division of Novartis, has joined its New York office as a partner.

With more than 25 years of in-house and private practice experience, Robin offers a pragmatic approach to the practice of law, having earlier served as in-house counsel at Novartis, one of the world’s largest healthcare companies, and Diageo, a global leader in premium drinks.

Linda Addison, US Managing Partner, Norton Rose Fulbright, said:

“Robin’s pharmaceutical industry background and in-house experience give her a perspective that enables her to relate in a unique way to our clients, especially those in the life sciences and healthcare sector.”

Robin has litigated commercial disputes, class actions and multi-jurisdictional cases before United States federal and state courts. She has represented clients in government enforcement actions by the Federal Trade Commission, the Department of Justice, the Department of Health and Human Services Office of the Inspector General and State Attorneys General. She also is known for her antitrust expertise, having advised clients with respect to issues arising in mergers and acquisitions, joint ventures, trade association activities, distribution practices, pricing programs and other aspects of competitor and customer communications and associations.

Rick Robinson, Global Co-Head of Life Sciences and Healthcare, Norton Rose Fulbright, commented:

“Robin is well known among her peers for her problem-solving capabilities in matters lying at the intersection of antitrust and intellectual property law. Her practical perspectives on complicated legal issues will greatly benefit our life sciences and healthcare clients.”

Robin, who is known for her collaborative style with business leaders, said:

“Having overseen the legal department of a multibillion-dollar pharmaceutical company, I can offer additional insight when collaborating with my talented colleagues on sophisticated matters. I know first-hand the importance of providing prompt, accurate and practical advice on legal and compliance issues, while balancing complex business objectives. I look forward to providing world-class service to Norton Rose Fulbright clients globally.”

Robin received her JD from New York University School of Law and her AB, magna cum laude, in Economics and Political Science from Colgate University.

Notes for editors:

Norton Rose Fulbright

Norton Rose Fulbright is a global legal practice. We provide the world’s pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers and other legal staff based in more than 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

For more information about Norton Rose Fulbright, see nortonrosefulbright.com/legal-notices.

Law around the world
nortonrosefulbright.com

Contacts

Norton Rose Fulbright
Dan McKenna, +1 713 651 3576
Director of Communications – United States
dan.mckenna@nortonrosefulbright.com

Contacts

Norton Rose Fulbright
Dan McKenna, +1 713 651 3576
Director of Communications – United States
dan.mckenna@nortonrosefulbright.com